Epsilen Bio
Milan
About Epsilen Bio
Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases. Epsilen Bio's mission is to develop therapies for patients affected by underserved medical conditions, through stable genomic epigenetic silencing of genes involved in pathological processes. The company was founded in December 2019 and based in Milan, Italy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Seed (Apr 2020)
- Website: epsilenbio.com
- Phone: 39 02 83991325
Industries & Categories
Biotechnology, Health Care, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/epsilen-bio-669978 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.